40
Participants
Start Date
June 30, 2008
Primary Completion Date
July 31, 2009
Study Completion Date
July 31, 2009
Vinorelbine oral
Vinorelbine at dose levels of 30mg, 40mg, 50mg, 60mg oral every Monday, Wednesday and Friday
Capecitabine
Capecitabine at dose levels of 800 mg/m2, 950mg/m2, 1100mg/m2, 1250mg/m2 per os from day 1 to day 14 every 21 days
University General Hospital of Alexandroupolis, Dept. of Medical Oncology, Alexandroupoli
"IASO General Hospital of Athens, 1st Dep of Medical Oncology", Athens
"Marika Iliadis Hospital of Athens, Dep of Medical Oncology", Athens
University Hospital of Crete, Dep of Medical Oncology, Heraklion
Lead Sponsor
University Hospital of Crete
OTHER
Hellenic Oncology Research Group
OTHER